Location
United States, North America
Cheque size
$1M - $75M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Pharmaceuticals
About Investor
Jim Sullivan is a Venture Partner at OrbiMed and co-founder & CEO of Vanqua Bio, a biotech company developing therapies for neurodegenerative diseases. At OrbiMed he is associated with early-stage life-sciences investments in biotech, pharma, digital health and health IT, generally in the $1M–$75.0M range. His career prior to OrbiMed includes serving as Vice President of Discovery at AbbVie, where he led research across oncology, immunology, neurology, hepatitis C and cystic fibrosis, and he has advanced more than 100 compounds into clinical development.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.